ライフサイエンスコーパス: apnea-hypopnea index

1 raphy to determine SDB severity (obstructive apnea-hypopnea index).

2 es in leg fluid volume and either DeltaNC or apnea-hypopnea index.

3 obstructive sleep apnea was assessed by the apnea-hypopnea index.

4 en the groups and correlated negatively with apnea-hypopnea index.

5 Nocturnal polysomnography to evaluate apnea-hypopnea index.

6 andard overnight sleep study to determine an apnea-hypopnea index.

7 ifferent gradations of OSA severity based on apnea-hypopnea index.

8 provement in nocturnal oxygen saturation and apnea/hypopnea index.

9 s were matched for age, body mass index, and apnea/hypopnea index.

10 Seventy-one subjects (ages, 55-76 yr; apnea-hypopnea index, 0.2-96.6 events/h) were evaluated

11 with coronary artery disease [CAD] and OSA [apnea-hypopnea index 15 events/h] with Epworth Sleepines

12 ith paroxysmal AF and moderate to severe SA (apnea-hypopnea index 15).

13 (29 male) with Cheyne-Stokes breathing (mean apnea-hypopnea index 19.8 [SD 2.6] and stable symptomati

14 ft tissue structures in 48 control subjects (apnea-hypopnea index, 2.0 +/- 1.6 events/hour) and 48 pa

15 ; mean [SD] age, 61.2 [8.7] years; mean [SD] apnea-hypopnea index, 31.2 [17] events per hour; 71% wit

16 ), and had severe OSA at baseline (mean [SD] apnea-hypopnea index, 33.1 [14.9] events/h).

17 We recruited 30 obese control subjects (apnea-hypopnea index, 4.7 +/- 3.1 events per hour) and 7

18 ge, 54 [10] yr; median [interquartile range] apnea-hypopnea index, 41 [35-53]; mean [SD] Epworth slee

19 Seventeen subjects (apnea-hypopnea index, 42.6 +/- 6.2 [SEM]) were studied d

20 our) and 72 obese patients with sleep apnea (apnea-hypopnea index, 43.5 +/- 28.0 events per hour).

21 ents/hour) and 48 patients with sleep apnea (apnea-hypopnea index, 43.8 +/- 25.4 events/hour).

22 tive sleep apnea (75% male; mean age, 52 yr; apnea-hypopnea index, 49/h; baseline sleepiness score, 1

23 A 64-year-old male patient with severe OSA (Apnea-Hypopnea Index, 54 events/h) underwent implantatio

24 OSA prevalence was 65% (median apnea-hypopnea index, 7.2; range, 0-93), 40% of which we

25 Home sleep testing was used to measure the apnea-hypopnea index, a measure of SDB severity.

26 Nasal occlusion increased the apnea hypopnea index (AHI) (occlusion mean = 6.6 +/- 8.0

27 SDB was quantified with the apnea hypopnea index (AHI) and oxygen desaturation measu

28 metabolites and their associations with the apnea hypopnea index (AHI) and with moderate-severe OSA

29 Apnea-predominant OSA was defined as an apnea hypopnea index (AHI) greater than 2 with more than

30 association of head and facial form with the apnea hypopnea index (AHI) in 364 white individuals and

31 re was a significant correlation between the apnea hypopnea index (AHI) measured by polysomnography a

32 d by urinary cotinine levels and obstructive apnea hypopnea index (AHI) scores.

33 A greater reduction in apnea hypopnea index (AHI) was strongly associated with

34 ure mapping on three primary OSA traits [the apnea hypopnea index (AHI), overnight average oxyhemoglo

35 vided by height in meters squared), sex, and apnea hypopnea index (AHI).

36 leep fragmentation, all participants with an apnea-hypopnea index (AHI) > or = 1 were analyzed separa

37 structive sleep apnea was assessed using the apnea-hypopnea index (AHI) (>=4% oxygen saturation crite

38 Two SDB definitions were considered: 1) apnea-hypopnea index (AHI) 5 and 2) oxygen desaturation

39 The association between post-treatment apnea-hypopnea index (AHI) and arousal threshold percent

40 r the OSA-associated quantitative phenotypes apnea-hypopnea index (AHI) and body mass index (BMI).

41 on sessions for all participants with a high apnea-hypopnea index (AHI) and by 37% (P = 0.008) among

42 Between-group differences on the apnea-hypopnea index (AHI) and Epworth sleepiness scale

43 of portable monitors, or association between apnea-hypopnea index (AHI) and health outcomes among com

44 A polysomnographically derived apnea-hypopnea index (AHI) and hypoxemia index (percent

45 The apnea-hypopnea index (AHI) and oxygen desaturation index

46 Apnea-hypopnea index (AHI) and percent nighttime with ox

47 d significant dose-relationships between REM apnea-hypopnea index (AHI) and prevalent hypertension.

48 rospectively evaluate the association of the apnea-hypopnea index (AHI) and sleep-related hypoxia wit

49 SDB was categorized using the apnea-hypopnea index (AHI) and the hypoxemia index (perc

50 risk for all-cause mortality, with FEV1 and apnea-hypopnea index (AHI) as the primary exposure indic

51 The main outcomes were apnea-hypopnea index (AHI) change and nightly device use

52 sleep-disordered breathing, depending on the apnea-hypopnea index (AHI) cutoff, ranged from 40 to 60%

53 signals in a one-dimensional (1D) format for Apnea-Hypopnea Index (AHI) estimation in pediatric subje

54 imary outcomes were safety and the change in apnea-hypopnea index (AHI) from baseline to 12 months po

55 The primary end point was the change in the apnea-hypopnea index (AHI) from baseline to the interven

56 moderate to severe SDB, defined as having an Apnea-Hypopnea Index (AHI) greater than 15 as assessed b

57 In fully adjusted models, patients with apnea-hypopnea index (AHI) greater than 30 had a 30% hig

58 week, on a nondialysis day, subjects with an apnea-hypopnea index (AHI) greater than or equal to 20 h

59 revalence of periodontal disease between the apnea-hypopnea index (AHI) groups, with a negligible Spe

60 ociation analyses in independent cohorts for apnea-hypopnea index (AHI) in a total of 7,708 individua

61 o detect SDB events and estimate whether the apnea-hypopnea index (AHI) is >= 15, indicative of moder

62 Women with an apnea-hypopnea index (AHI) less than 10 comprised the co

63 Women with an apnea-hypopnea index (AHI) less than 10 were the control

64 Patients with an apnea-hypopnea index (AHI) less than 15 were the control

65 o 12.9 years with snoring and an obstructive apnea-hypopnea index (AHI) less than 3 enrolled at 7 US

66 Nonetheless, an obstructive apnea-hypopnea index (AHI) of 1 or greater is often used

67 patients with resistant hypertension and an apnea-hypopnea index (AHI) of 15 or higher.

68 ricular ejection fraction of 45% or less, an apnea-hypopnea index (AHI) of 15 or more events (occurre

69 A total of 14.7% of subjects with an apnea-hypopnea index (AHI) of 15 or more had a diagnosis

70 th recently diagnosed (<6 months) OSA and an apnea-hypopnea index (AHI) of 20 events/hour or more.

71 patients with moderate to severe OSA with an apnea-hypopnea index (AHI) of 20 to 65 events per hour a

72 OSA was defined as a nightly mean apnea-hypopnea index (AHI) of more than 15 events/h.

73 50% reduction or greater in preimplantation Apnea-Hypopnea Index (AHI) score and postimplantation AH

74 Outcomes were the apnea-hypopnea index (AHI) score, ascertained via polyso

75 The prevalence varies based on the apnea-hypopnea index (AHI) threshold used for the evalua

76 Mean apnea-hypopnea index (AHI) was 52.6 +/- 28.2 (SD) events

77 The apnea-hypopnea index (AHI) was derived from standardized

78 SE).Measurements and Main Results: Change in apnea-hypopnea index (AHI) was measured.

79 ed with a tomograph and corneal topographer, apnea-hypopnea index (AHI) with polysomnography, and ser

80 e and BUI intensity were associated with the apnea-hypopnea index (AHI), a measure of severity of apn

81 For OSA, facial shape correlated with the apnea-hypopnea index (AHI), and DS individuals with seve

82 nce of OSA, physiological data including the apnea-hypopnea index (AHI), and nocturnal oxygen saturat

83 r, OAs have variable success at reducing the apnea-hypopnea index (AHI), and predicting responders is

84 ated with hsCRP and MRP 8/14 levels and with apnea-hypopnea index (AHI), BMI z score, and apolipoprot

85 Our main exposures were the obstructive apnea-hypopnea index (AHI), central apnea index (CAI >/=

86 ed into four severity groups on the basis of apnea-hypopnea index (AHI), followed by comparisons of c

87 In combination with apnea-hypopnea index (AHI), identification of "respirato

88 g the value of the ODI as a surrogate to the apnea-hypopnea index (AHI), it was shown that the value

89 nography study that obtained measurements of apnea-hypopnea index (AHI), peripheral oxygen saturation

90 es included oxygen desaturation index (ODI), apnea-hypopnea index (AHI), subjective sleepiness (Epwor

91 Rationale: The apnea-hypopnea index (AHI), used for the diagnosis of ob

92 y was associated with a 55% reduction in the apnea-hypopnea index (AHI), which decreased from a prefl

93 Logistic regression assessed apnea-hypopnea index (AHI)-adjusted associations between

94 p-disordered breathing was quantified by the apnea-hypopnea index (AHI)-the average number of apneas

95 e sleep apnea (OSA) have been defined by the apnea-hypopnea index (AHI).

96 oss individuals and are not predicted by the apnea-hypopnea index (AHI).

97 for the diagnosis of OSAS and calculation of Apnea-Hypopnea Index (AHI).

98 rence, hours of use, mask leak, and residual apnea-hypopnea index (AHI).

99 e changes would correlate with reductions in apnea-hypopnea index (AHI).Methods: A total of 67 indivi

100 OSA severity was defined by the apnea-hypopnea index (AHI): severe >30, moderate >15-30,

101 Apnea-hypopnea index (AHI, the average number of apneas

102 The primary end point was the change in the apnea-hypopnea index (AHI, the number of apneas and hypo

103 Outcome measures included apnea-hypopnea index (AHI; average number of apneas plus

104 Primary outcome measures were the apnea-hypopnea index (AHI; ie, the number of apnea and h

105 The primary outcome measures were the apnea-hypopnea index (AHI; the number of apnea or hypopn

106 OSAS was defined by an apnea/hypopnea index (AHI) greater than or equal to 1 ev

107 a resolution of symptoms and a reduction in Apnea/Hypopnea Index (AHI) to < 5/h, and partial respons

108 p was divided into 3 sub-groups based on the apnea/hypopnea index (AHI): mild, moderate, or severe OS

109 ne 30, 1997, and had to have normal results (apnea hypopnea index [AHI] <5).

110 al of 126 patients with moderate-severe OSA (apnea hypopnea index [AHI], 25.6 [SD 12.3]) were randoml

111 of hypersomnolence in 741 patients with SDB (apnea-hypopnea index [AHI] >/= 10 events/h).

112 Mild to severe OSA (apnea-hypopnea index [AHI] >=5) was associated with poor

113 The prevalence of severe (apnea-hypopnea index [AHI] 30) and nonsevere (AHI <30) O

114 surgical responses (>/=50% reduction in the apnea-hypopnea index [AHI] and <10 events/hour) in patie

115 participants were identified as free of OSA (apnea-hypopnea index [AHI] of <5 events/h and not treate

116 frequency of apneas and hypopneas using the Apnea-Hypopnea Index [AHI]) and sleep-related hypoxemia

117 terval 1.00 to 1.21] per 10-unit increase in apnea-hypopnea index [AHI]) but not in older men or in w

118 in 68 patients (55 males, 13 females; median apnea-hypopnea index [AHI], 35) not receiving hypotensiv

119 We examined 55 sleep apnea probands (apnea-hypopnea index [AHI]: 43.2 +/- 26.3 events/h), 55

120 antimuscarinic (oxybutynin) on OSA severity (apnea-hypopnea index [AHI]; primary outcome) and geniogl

121 A total of 25 adults with positional OSAS (apnea-hypopnea index [AHI]supine:AHInon-supine >/= 2) we

122 both sleep laboratory and clinical criteria (apnea/hypopnea index [AHI] > or = 10 and the presence of

123 The 24-h prevalence of predominant CAs (apnea/hypopnea index [AHI] >/=5 events/h, with CA of >50

124 ecutive new outpatients diagnosed with SAHS (apnea/hypopnea index [AHI] >or= 5/hour, and >or= 2 sympt

125 ore episodes of apnea and hypopnea per hour (apnea-hypopnea index, AHI).

126 y of apneas and hypopneas per hour of sleep (apnea-hypopnea index, AHI).

127 was observed between either the obstructive apnea-hypopnea index and any aggregation parameter, but

128 on was used to model the association between apnea-hypopnea index and echocardiographic measures whil

129 subjects, which directly correlated with the apnea-hypopnea index and hypoxemic indices.

130 For each interval, we assessed the median apnea-hypopnea index and the relative risk of sudden dea

131 ents per hour or <15/h, respectively, on the apnea-hypopnea index) and the median PWAD index.

132 Body mass index, apnea-hypopnea index, and cognitive abilities were model

133 iac biomarker expression, functional status, apnea-hypopnea index, and overnight hypoxemia.

134 of sleep time with oxygen saturation < 90%, apnea-hypopnea index, and oxygen desaturation index-did

135 ea or Cheyne-Stokes respiration, obstructive apnea-hypopnea index, and percentage of sleep time with

136 rs11691765, GPR83, P = 1.90 x 10(-8) for the apnea-hypopnea index, and rs35424364; C6ORF183/CCDC162P,

137 en saturation as measured by pulse oximetry, apnea-hypopnea index, and the fraction of events that we

138 (OSA) is variable when considering only the Apnea Hypopnea Index as the treatment end point.

139 e four-year follow-up study according to the apnea-hypopnea index at base line were estimated after a

140 The effects of severe apnea (apnea-hypopnea index, at least 30 episodes/h), which occ

141 om 12-channel home polysomnography, were the apnea-hypopnea index (average number of apneas/hypopneas

142 s were metaanalyzed for association with the apnea-hypopnea index, average oxygen saturation during s

143 incident CVD experienced larger increases in apnea-hypopnea index between polysomnograms.

144 as experiencing at least a 50% reduction in apnea-hypopnea index between sham and active treatment.

145 The relation of incident CVD to change in apnea-hypopnea index between the 2 polysomnograms was te

146 ion was assessed for baseline sleep indices: apnea-hypopnea index, central sleep apnea (central apnea

147 The difference in adjusted mean apnea-hypopnea index change between subjects with and wi

148 rdiac causes during other intervals, and the apnea-hypopnea index correlated directly with the relati

149 Mean number of events measured by the apnea-hypopnea index decreased from 35.7/h to 2.1/h at 6

150 Apnea hypopnea index, defined as number of apneas and hy

151 The apnea-hypopnea index does not capture the range of physi

152 his hypothesis, we correlated loop gain with apnea-hypopnea index during supine, nonrapid eye movemen

153 We used the apnea-hypopnea index (events per hour) to define obstruc

154 STM reduced the apnea-hypopnea index from 55.2 to 33.0 events/h (-41.0%)

155 ntification of all children with obstructive apnea-hypopnea index greater than 5/hour total sleep tim

156 e participants with obstructive sleep apnea (apnea-hypopnea index > 5 events/hr) were administered an

157 ss quality of life in 122 patients with SDB (apnea-hypopnea index > or = 5 events/hour), this study f

158 with polysomnography between 1992 and 2004 (apnea-hypopnea index > or =15) who subsequently underwen

159 overweight/obese matched patients with OSA (apnea-hypopnea index >/= 15 events per hour) and 11 norm

160 OSA (apnea-hypopnea index >/= 5 events/h) was assessed using

161 SDB was characterized by apnea-hypopnea index >/=15 events per hour (polysomnogra

162 derate-to-severe sleep-disordered breathing (apnea-hypopnea index >/=15%) was significantly higher in

163 ients with newly revascularized CAD and OSA (apnea-hypopnea index >/=15/h) without daytime sleepiness

164 with paroxysmal AF (43 with >/=moderate OSA [apnea-hypopnea index >/=15] and 43 without OSA [apnea-hy

165 best predicted by age >60 years (HR: 5.53), apnea-hypopnea index >20 (HR: 1.60), mean nocturnal O2sa

166 To evaluate the presence of OSA (apnea-hypopnea index >= 15 events . h(-1)), all patients

167 .Methods: Data from 1,207 patients with OSA (apnea-hypopnea index >= 15 events/h) were used to evalua

168 20 participants with moderate-to-severe OSA (apnea-hypopnea index >=15 events per hour) were randomiz

169 The presence of SDB (defined as apnea-hypopnea index >=15/h) was assessed with a portabl

170 ed that, for clinically defined sleep apnea (apnea/hypopnea index > or = 10 and daytime symptoms), me

171 women diagnosed with moderate to severe OSA (apnea-hypopnea index, >/=15) in 19 Spanish sleep units.

172 eepiness: severe sleep-disordered breathing (apnea-hypopnea index, >30 episodes/hr), self-report of p

173 M and non-REM sleep was quantified using the apnea-hypopnea index in REM (AHIREM) and non-REM sleep (

174 correlation was found between loop gain and apnea-hypopnea index in the atmospheric group only (r =

175 At baseline, the mean apnea-hypopnea index in the patients with the syndrome w

176 for mortality, but its diagnostic metric-the apnea-hypopnea index-is a poor risk predictor.

177 18 overweight/obese subjects without apnea (apnea-hypopnea index < 15 events per hour) with 25 overw

178 ife in normal subjects (n = 15) without SDB (apnea-hypopnea index < 5 events/hour) recruited from the

179 When compared with individuals without OSA (apnea-hypopnea index < 5), significantly increased risk

180 to moderate degrees of sleep apnea (5 < or = apnea-hypopnea index < or = 30).

181 ears with snoring and mild oSDB (Obstructive Apnea-Hypopnea Index <3 with tonsillar hypertrophy [Brod

182 lectomy for mSDB (snoring and an obstructive apnea-hypopnea index <3) between June 29, 2016, and Febr

183 ea-hypopnea index >/=15] and 43 without OSA [apnea-hypopnea index <5]), right atrial and left atrial

184 of 1 to each criterion that was satisfied: (apnea-hypopnea index, <30 events per hour) + (nadir oxyg

185 aphic factors (mean age, 63 yr; 52% female), apnea-hypopnea index (mean, 13.8; SD, 15.0), smoking, an

186 derate to severe sleep-disordered breathing (apnea-hypopnea index, measured as events/hour, >/=15) ar

187 es, death, sleep study measures (such as the Apnea-Hypopnea Index), measures of cardiovascular status

188 ith mild SDB, all of whom had an obstructive apnea-hypopnea index (OAHI) no greater than 3.

189 ged between 2 to 4 years with an Obstructive Apnea-Hypopnea Index (OAHI) score of 2 or greater and le

190 omnography, and severe SDB was defined as an apnea-hypopnea index of >30 per hour of sleep.

191 Relative to the reference category of an apnea-hypopnea index of 0 events per hour at base line,

192 t confidence interval, 1.13 to 1.78) with an apnea-hypopnea index of 0.1 to 4.9 events per hour at ba

193 d adjusted rate ratio [caffeine/placebo] for apnea-hypopnea index of 0.89 [95% CI = 0.55-1.43]; P = 0

194 Sleep-disordered breathing was defined as an apnea-hypopnea index of 15 or more events per hour of sl

195 he prevalence of sleep-disordered breathing (apnea-hypopnea index of 15 or more) among hormone users

196 Participants with an apnea-hypopnea index of 15 to 50 events per hour were ra

197 t confidence interval, 1.46 to 5.64) with an apnea-hypopnea index of 15.0 or more events per hour.

198 the syndrome was 35, as compared with a mean apnea-hypopnea index of 2 in the comparison group.

199 onsecutive patients were enrolled who had an apnea-hypopnea index of 20 h(-1) or greater and an Epwor

200 ructive sleep apnea syndrome was based on an apnea-hypopnea index of 5 or higher (five or more events

201 founders.Measurements and Main Results: SDB (apnea-hypopnea index of 5 or more) and insomnia (Women's

202 t confidence interval, 1.29 to 3.17) with an apnea-hypopnea index of 5.0 to 14.9 events per hour, and

203 e or more events per hour); patients with an apnea-hypopnea index of less than 5 served as the compar

204 An apnea-hypopnea index of more than 10 per hour was signif

205 omes were total sleep time on actigraphy and apnea-hypopnea index on polysomnography.

206 leep-disordered breathing was ascertained by apnea-hypopnea index or clinical diagnosis.

207 al apnea (OR, 6.31; 95% CI, 1.94-20.51), and apnea-hypopnea index (OR, 1.22; 95% CI, 1.08-1.39 [per 5

208 associated with significant improvements in apnea-hypopnea index (P < 0.001); microarousal index (P

209 idal carbon dioxide were determinants of the apnea-hypopnea index (P value range = 0.04-0.001).

210 versely with DeltaNC (r=-0.755, P<0.001) and apnea-hypopnea index (r=-0.765, P<0.001), it did not in

211 ificant positive correlation between SAA and apnea-hypopnea index (r=0.40, P=0.03).

212 The apnea-hypopnea index reduction threshold of 50% was reac

213 saturation (SaO2); right putamen tCho/Cr and apnea hypopnea index; right putamen GABA/Cr and baseline

214 mes were nocturnal oxygen saturation and the apnea/hypopnea index; secondary outcomes were sleep stru

215 us mean diffusivity correlated with a higher apnea hypopnea index (Spearman's r = -0.50, p = 0.008) a

216 idnight to 6 a.m. had a significantly higher apnea-hypopnea index than those with sudden death from c

217 leep-disordered breathing, as defined by the apnea-hypopnea index (the number of episodes of apnea an

218 SDB classified via polysomnography using apnea-hypopnea index thresholds, with subtypes including

219 classified based on conventionally accepted apnea/hypopnea index thresholds: >=5.0/h (OSA(>=5)), >=1

220 oke or cardiovascular events with increasing apnea-hypopnea index values.

221 Median apnea hypopnea index was 6.0 (IQR, 3.1-10.3) events per

222 The mean apnea-hypopnea index was 16 (95% CI, 13-19), and the mea

223 Mean (SEM) apnea-hypopnea index was also significantly higher in pa

224 Each 10-unit increase in apnea-hypopnea index was associated with 0.2 (95% CI, 0.

225 Initially, the apnea-hypopnea index was determined by polysomnography f

226 e, diabetes mellitus, and creatinine levels, apnea-hypopnea index was independently associated with i

227 The mean (+/-SD) of apnea-hypopnea index was significantly higher in patient

228 bjects (1,839 in fully adjusted models), the apnea-hypopnea index was used to classify OSA as none (0

229 and 2590 m than placebo and autoCPAP: median apnea/hypopnea index was 5.8 events per hour (5.8/h) (IQ

230 y of apneas and hypopneas per hour of sleep (apnea-hypopnea index) was determined by unattended, sing

231 uch as age, race and ethnicity, obesity, and apnea-hypopnea index, were not associated with improveme

232 studies focused on traits defined using the apnea-hypopnea index, which contains limited information

233 (Epworth Sleepiness Scale score >10) and an apnea-hypopnea index with 3% desaturation and from 5 to

234 Apnea-hypopnea index with a 4% desaturation criterion (p

235 Apnea-hypopnea index with a 4% desaturation criterion de